KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scotts Miracle-Gro (SMG) Capital Expenditures (2016 - 2025)

Scotts Miracle-Gro's Capital Expenditures history spans 17 years, with the latest figure at $20.0 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 31.74% year-over-year to $20.0 million; the TTM value through Dec 2025 reached $88.1 million, up 16.84%, while the annual FY2025 figure was $97.4 million, 15.95% up from the prior year.
  • Capital Expenditures for Q4 2025 was $20.0 million at Scotts Miracle-Gro, down from $42.9 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $46.1 million in Q1 2022 and bottomed at $8.3 million in Q1 2025.
  • The 5-year median for Capital Expenditures is $22.0 million (2023), against an average of $24.5 million.
  • The largest annual shift saw Capital Expenditures tumbled 50.0% in 2022 before it soared 158.43% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $29.0 million in 2021, then increased by 2.07% to $29.6 million in 2022, then rose by 28.04% to $37.9 million in 2023, then decreased by 22.69% to $29.3 million in 2024, then plummeted by 31.74% to $20.0 million in 2025.
  • Per Business Quant, the three most recent readings for SMG's Capital Expenditures are $20.0 million (Q4 2025), $42.9 million (Q3 2025), and $16.9 million (Q2 2025).